News
Brinker, the owner of Chili's, has seen shares soar 20% so far in 2025. The earnings report on Tuesday could take them a leg up or down. The additional step, which could cost millions of dollars, goes ...
Amazon, Apple, Meta, and Microsoft will need to address tariffs on earnings calls next week. Tech executives are sounding alarms. Brinker, the owner of Chili's, has seen shares soar 20% so far in 2025 ...
7h
Stocktwits on MSNNovavax Tops Weekly Retail Buzz Spike Amid FDA Trial Drama, COVID-19 Vaccine Approval HopesNovavax, Inc. (NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following ...
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
A summary of current health news, including the disbanding of a U.S. Justice Department unit focusing on food and drug safety ...
Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5%. For the week, the S&P advanced +4 ...
The U.S. Food and Drug Administration (FDA) is still negotiating whether to grant full approval to Novavax's COVID-19 vaccine ...
Measles would likely be the first eradicated disease to return, because it is so highly contagious, but other diseases like ...
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
Health-care companies rose as earnings continued to come in strong. AbbVie shares rose after the drugmaker posted earnings ahead of Wall Street targets.
Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results